Clicky

  • Login
  • Register
  • Submit Your Content
  • Contact Us
Thursday, July 3, 2025
World Tribune
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
Submit
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food
No Result
View All Result
World Tribune
No Result
View All Result

Functional medicine LLM developed in Malaysia and more briefs

July 1, 2025
in Health
Reading Time: 2 mins read
A A
Functional medicine LLM developed in Malaysia and more briefs
0
SHARES
ShareShareShareShareShare

Functional medicine LLM developed in Malaysia and more briefs

LLM for functional medicine developed in Malaysia

Emagene.Life, an alternative medicine provider focused on longevity, has unveiled a large language model-based (LLM) platform for functional medicine. 

Based on a media release, the LLM-driven platform provides insights into a patient’s unique profile, which can inform clinicians’ personalised supplement and lifestyle recommendations. 

It accelerates laboratory data analysis by unifying and standardising blood biomarker data from around the world. 

The LLM platform is the product of 18 months of research and development by Emagene’s deep technology company, Avio Health. 


Taiwanese startup scores 510(k) for brain surgery robot

Taiwan-based medical robotics company Brain Navi has obtained regulatory clearance in the United States for its neurosurgical navigation robot. 

READ ALSO

Teleflex finalizes acquisition of Biotronik

NHS to develop AI system to target patient safety issues

It received a 510(k) clearance from the US Food and Drug Administration for its flagship robotic system, which combines AI-driven precision and robotic automation to support various brain surgery procedures, including biopsies, tumour ablations, endoscopic interventions, EVD placement, SEEG, and Deep Brain Stimulation. 

The clearance adds to Brain Navi’s regulatory approvals in Taiwan and Europe, and enables it to market the robotic system to US hospitals and surgical teams. 


Daewoong Pharmaceutical to release genAI hospital solutions

Daewoong Pharmaceutical is developing new smart hospital solutions powered by generative AI. 

It has signed a memorandum of understanding with two technology companies, Sears Technology and Puzzle AI, to create a line of genAI-based smart hospital solutions that incorporate voice-based clinical documentation, AI-powered medical record automation, and real-time patient monitoring, which will have applications in various healthcare settings.

As part of the partnership, Puzzle AI will provide its voice-based clinical documentation tool, GenNote. Sears will link this clinical note-taking tool to Daewoong’s patient monitoring system, ThynC.

The partners plan to conduct validation studies and promote and roll out their solutions to hospitals in the future.

Credit: Source link

ShareTweetSendSharePin
Previous Post

Taiwan dollar surges more than 2% as traders test central bank

Next Post

Bank of England boss sees interest rates trending ‘downwards’

Related Posts

Teleflex finalizes acquisition of Biotronik
Health

Teleflex finalizes acquisition of Biotronik

July 2, 2025
NHS to develop AI system to target patient safety issues
Health

NHS to develop AI system to target patient safety issues

July 2, 2025
Nordic Capital acquires majority stake in Arcadia
Health

Nordic Capital acquires majority stake in Arcadia

July 2, 2025
NZ’s digital breast screening platform goes live and more briefs
Health

NZ’s digital breast screening platform goes live and more briefs

July 2, 2025
Judge approves 23andMe sale amid privacy dispute
Health

Judge approves 23andMe sale amid privacy dispute

July 1, 2025
Suki expands integration with Meditech’s EHR platform
Health

Suki expands integration with Meditech’s EHR platform

July 1, 2025
Next Post
Bank of England boss sees interest rates trending ‘downwards’

Bank of England boss sees interest rates trending 'downwards'

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

What's New Here!

Everything Apple announced for its wearable at WWDC 2025

Everything Apple announced for its wearable at WWDC 2025

June 9, 2025
Can Eutelsat become Europe’s alternative to Starlink?

Can Eutelsat become Europe’s alternative to Starlink?

June 29, 2025
This Fortune 500 CEO drinks at least 300 milligrams of caffeine per day. Is that safe?

This Fortune 500 CEO drinks at least 300 milligrams of caffeine per day. Is that safe?

June 6, 2025
Ford CEO says new technologies like AI are leaving many workers behind, and companies need a plan

Ford CEO says new technologies like AI are leaving many workers behind, and companies need a plan

June 28, 2025
Stock updates for the new console and accessories

Stock updates for the new console and accessories

June 11, 2025
Coinbase secures EU crypto license, swaps Ireland for Luxembourg

Coinbase secures EU crypto license, swaps Ireland for Luxembourg

June 20, 2025
Latest stock updates at Walmart, Best Buy and more

Latest stock updates at Walmart, Best Buy and more

June 25, 2025

About

World Tribune is an online news portal that shares the latest news on world, business, health, tech, sports, and related topics.

Follow us

Recent Posts

  • ‘Massive’ investment in R&D leads China’s Honor to launch world’s thinnest foldable phone
  • Ex-Met retires after 13 MLB seasons
  • House GOP stalls ahead of key vote
  • Barclays names Anne Marie Darling, who retired from Goldman Sachs in 2024, as co-COO

Newslatter

Loading
  • Submit Your Content
  • Contact Us
  • Privacy Policy
  • Terms of Use
  • DMCA

© 2024 World Tribune - All Rights Reserved!

No Result
View All Result
  • Home
  • News
  • Business
  • Technology
  • Sports
  • Health
  • Food

© 2024 World Tribune - All Rights Reserved!

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In